InvestorsHub Logo
Followers 84
Posts 32220
Boards Moderated 85
Alias Born 03/22/2005

Re: DewDiligence post# 43

Monday, 03/13/2017 9:20:27 AM

Monday, March 13, 2017 9:20:27 AM

Post# of 387
Dew, Any idea on how much salmon production AQB will have available from their Panama facility? I see they are considering a facility in North America also -


>>> Specifically, management is evaluating several paths to revenue generation that follow different timelines, including production of AquAdvantage [®] fish at the Company's existing farm in Panama, purchase of an existing production facility in North America, and construction of a new production facility in North America. <<<



Not having to use antibiotics and vaccines in their salmon will be a big selling point that will help balance out the GMO aspect from a consumer acceptance standpoint. And their land-based approach appears to have many advantages over the traditional open-sea cage fish farming method -



>>> Our game-changing platform affords better economics for land-based aquaculture and all the advantages that it brings, including nutritious Atlantic salmon free of antibiotics, vaccines, and other treatments that are necessary to minimize infection in fish farming today," added Dr. Stotish <<<



http://www.marketwatch.com/story/aquabounty-announces-completion-of-nasdaq-listing-and-equity-subscription-from-intrexon-2017-01-19?siteid=bigcharts&dist=bigcharts





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AQB News